pancreatic-cancer

Documents about pancreatic-cancer

• Prospective Cohort Study of Pancreatic Cancer Patients Treated With Proton Beam Therapy#885923ClinicalTrials.gov
• A Study of DCTY1102 Injection in Participants With Advanced Solid Tumors#908444ClinicalTrials.gov
• A Prospective, Single-arm, Exploratory Clinical Study of Sintilimab Injection in Combination With Paclitaxel (Albumin-bound) and Gemcitabine in Translational Therapy in Patients With Unresectable Locally Advanced Pancreatic Cancer.#314330ClinicalTrials.gov
• A Multicenter, Open-label, Phase II Umbrella Study to Evaluate the Efficacy and Safety of the Investigational Product in Participants With Advanced or Metastatic Pancreatic Cancer#803485ClinicalTrials.gov
• Integrated Care Pathway in Oncology (PASSION)#902625ClinicalTrials.gov
• Guadecitabine and Durvalumab in Treating Patients With Advanced Liver, Pancreatic, Bile Duct, or Gallbladder Cancer#886466ClinicalTrials.gov
• Michigan Genetic Hereditary Testing (MiGHT)#906879ClinicalTrials.gov
• Vaccine Therapy, Interleukin-2, and Sargramostim in Treating Patients With Advanced Tumors#123552ClinicalTrials.gov
• A Clinical Research of CAR T Cells Targeting EpCAM Positive Cancer#332745ClinicalTrials.gov
• Effects of Peptamen 1.6 in Malnourished Patients (or at Risk) With Pancreatic Neoplasia Undergoing Cephalic Pancreaticoduodenectomy (CPD): A Mechanistic Study#813211ClinicalTrials.gov
• Prognosis Prediction Model After Upfront Surgery for Resectable Pancreatic Ductal Adenocarcinoma: A Multicenter Study (OS-HBP-2)#345333OKAYAMA UNIVERSITY SCIENTIFIC ACHIEVEMENT REPOSITORY
• Preop Chemoradiation Resectable Pancreas#852043ClinicalTrials.gov
• Clinical Study of CLDN18.2 PET/CT for Noninvasive Diagnosis of Gastric and Pancreatic Cancer#854567ClinicalTrials.gov
• Synthesis of α-fluorocinnamate derivatives as novel cathepsin S inhibitors with in vitro antiproliferative activity against pancreatic cancer cells#427447IRIS
• An Open-label, Phase I/II Study of the Pan-immunotherapy in Patients With Local Advanced/Metastatic Pancreatic Cancer#895196ClinicalTrials.gov
• Blood Sample Collection to Evaluate Biomarkers in Subjects With Untreated Solid Tumors#811070ClinicalTrials.gov
• A Study of Entinostat and FOLFOX in Subjects With Pancreatic Adenocarcinoma#867144ClinicalTrials.gov
• A Clinical Research of CAR T Cells Targeting HER2 Positive Cancer#851882ClinicalTrials.gov
• A Phase I/II Study With CEA(6D) VRP Vaccine in Patients With Advanced or Metastatic CEA-Expressing Malignancies#127579ClinicalTrials.gov
• Immunotherapy Using Tumor Infiltrating Lymphocytes for Patients With Metastatic Cancer#394757ClinicalTrials.gov
• IMaging Pilot Study of the αvβ6 Integrin Radiotracer [18F]-A20FMDV2 in PAtients With Solid Cancer Types#832031ClinicalTrials.gov
• A Prospective Study of EUS Guided Celiac Block#855790ClinicalTrials.gov
• Ability of a Dendritic Cell Vaccine to Immunize Melanoma or Epithelial Cancer Patients Against Defined Mutated Neoantigens Expressed by the Autologous Cancer#256904ClinicalTrials.gov
• Malpractice claims for pancreatic cancer in Norway: claim-rates, injury domains, claim outcomes and indemnity compensation.#9495PubMed
• Efficacy of Chemopreventive Agents on Disease-free and Overall Survival in Patients With Pancreatic Ductal Adenocarcinoma: The CAOS Study#160313ClinicalTrials.gov
• Conditional knockout of hypoxia-inducible factor 1-alpha in tumor-infiltrating neutrophils protects against pancreatic ductal adenocarcinoma#379949DR-NTU (Digital Repository of NTU)
• Study to Evaluate the Safety and Efficacy of Treatment With NLM-001 and Standard Chemotherapy Plus Zalifrelimab in Patients With Advanced Pancreatic Cancer#398318ClinicalTrials.gov
• NUAK2 Inhibition Enhances Macromolecular Drug Delivery in a 3D Fibrotic Model of the Pancreatic Tumor Microenvironment#653887OKAYAMA UNIVERSITY SCIENTIFIC ACHIEVEMENT REPOSITORY
• Radiotherapy in Combination With TTI-101 in Borderline Resectable and Locally Advanced Pancreatic Ductal Adenocarcinoma#825682ClinicalTrials.gov
• AG Combined With Immunotherapy and SBRT in Patients With Potentially Resectable Pancreatic Cancer#834587ClinicalTrials.gov
• Dovitinib Lactate in Treating Patients With Pancreatic Neuroendocrine Tumors#836396ClinicalTrials.gov
• Feasibility of Obtaining and Characterizing Circulating Tumorigenic Cells in Patients With Pancreatic Adenocarcinoma#837637ClinicalTrials.gov
• Safety and Efficacy of Endoscopic Ultrasound (EUS) Guided Radiofrequency Ablation (RFA) in the Treatment of Pancreatic Lesions#839755ClinicalTrials.gov
• A Study of High Dose Radiation Therapy for Locally Advanced Pancreatic Cancer That Responded to Initial Chemotherapy Treatment#904802ClinicalTrials.gov
• A Study of a Personalized Cancer Vaccine Targeting Shared Neoantigens#426789ClinicalTrials.gov
• A Study of the GSK MEK Inhibitor GSK1120212 and Everolimus in Cancer Subjects#805671ClinicalTrials.gov
• Study of Gemcitabine, Abraxane® Plus Placebo Versus Gemcitabine, Abraxane® Plus 1 or 2 Truncated Courses of Demcizumab in Subjects With 1st-Line Metastatic Pancreatic Ductal Adenocarcinoma#873865ClinicalTrials.gov
• Administering Peripheral Blood Lymphocytes Transduced With a CD70-Binding Chimeric Antigen Receptor to People With CD70 Expressing Cancers#411394ClinicalTrials.gov
• Generation of Cancer Antigen-Specific T-cells From Human Induced Pluripotent Stem Cells (iPSC) for Research and Potential FutureTherapy#683084ClinicalTrials.gov
• Phase I - Escalating Dose Study of siG12D LODER (Local Drug EluteR) in Patients With Locally Advanced Adenocarcinoma of the Pancreas, and a Single Dose Study of siG12D LODER (Local Drug EluteR) in Patients With Non-operable Adenocarcinoma of the Pancreas#910830ClinicalTrials.gov
• Radiotherapy With Chemotherapy as Neoadjuvant Therapy of Resectable and Borderline Resectable Pancreas Cancer#839895ClinicalTrials.gov
• MRD in PAAD Adjuvant Therapy#859119ClinicalTrials.gov
• Performance of a blood-based RNA signature for gemcitabine-based treatment in metastatic pancreatic adenocarcinoma#213272HAL (France)
• Predictive Nomogram for Recurrence After Upfront Surgery for Resectable Pancreatic Ductal Adenocarcinoma: A Multicenter Study (OS-HBP-2)#345337OKAYAMA UNIVERSITY SCIENTIFIC ACHIEVEMENT REPOSITORY
• A Study of LY2157299 in Participants With Pancreatic Cancer That is Advanced or Has Spread to Another Part of the Body#843483ClinicalTrials.gov
• A Randomized Phase II/Genomic Trial of Two Chemotherapy Regimens in Patients With Resected Pancreatic Adenocarcinoma#894391ClinicalTrials.gov
• Effectiveness of Care in Certified Cancer Centres in Germany#806143ClinicalTrials.gov
• Feasibility Study: IGNITE-TX (Identifying Individuals for Genetic Testing & Treatment) Intervention#869816ClinicalTrials.gov
• Safety and Efficacy of CEA-targeted CAR-T for CEA-positive Advanced Malignant Solid Tumors#889170ClinicalTrials.gov
• DHHC7 palmitoylates KRAS4A and promotes mutant KRAS-driven pancreatic cancers#148841bioRxiv / medRxiv